PURPOSE: To evaluate the outcome and the prognosis of @entity1 with @entity69646 who were treated with @entity902 -based chemotherapy immediately after initial surgery. METHODS: We conducted a retrospective review of @entity1 with @entity43 who were referred for consideration of treatment to the Departments of Medical Oncology participating in the Hellenic Cooperative Oncology Group. RESULTS: Over a 14-year period 53 @entity1 were included in our study. There were 13 @entity1 with @entity5000 and 40 @entity1 with @entity5 . Forty percent of @entity1 underwent complete resection of their @entity5 . @entity902 -based chemotherapy consisted primarily of @entity900 , @entity5713 , and @entity1732 ( @entity7297 ) in 9 @entity1 ; @entity1732 , @entity2879 , and @entity900 ( @entity12962 ) in 15 @entity1 ; and @entity1732 , @entity2879 , and @entity3003 (BEC) in 25 @entity1 . With a median follow-up of 39 months, 5 @entity1 developed @entity74 and died of their @entity5 and 1 @entity1 died of @entity1732 -induced @entity358 with no evidence of active @entity5 . The 5-year overall survival was 100% for @entity1 with @entity5000 and 85% for @entity1 with @entity5 . Eighty percent of @entity1 with advanced @entity5 and @entity66 after surgery remain disease free. CONCLUSION: With this study we confirm that @entity1 with @entity69646 have a favorable outcome when treated with @entity902 -based chemotherapy.

Favorable outcome of @entity69646 treated with @entity900 or XXXX -based chemotherapy: a Hellenic Cooperative Oncology Group study.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity43 :: ('MESH:D010051', 'Disease') :: ['ovarian germ cell tumors'] @entity12962 :: ('CHEBI:34567', 'Chemical') :: ['BEP'] @entity69646 :: ('MESH:C562841', 'Disease') :: ['ovarian germ cell malignancies'] @entity66 :: ('MESH:D004194', 'Disease') :: ['residual disease'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor', 'nondysgerminomatous tumors', 'tumors'] @entity3003 :: ('MESH:D016190', 'Chemical') :: ['carboplatin'] @entity900 :: ('MESH:D002945', 'Chemical') :: ['cisplatin'] @entity2879 :: ('MESH:D005047', 'Chemical') :: ['etoposide'] @entity358 :: ('MESH:D008171', 'Disease') :: ['lung toxicity'] @entity5713 :: ('MESH:D014747', 'Chemical') :: ['vinblastine'] @entity1732 :: ('MESH:D001761', 'Chemical') :: ['bleomycin'] @entity7297 :: ('CHEBI:53285', 'Chemical') :: ['PVB'] @entity74 :: ('MESH:D030342', 'Disease') :: ['progressive disease'] @entity902 :: ('MESH:D010984', 'Chemical') :: ['Platinum', 'platinum'] @entity5000 :: ('MESH:D004407', 'Disease') :: ['dysgerminoma']
@entity3003 :: (MESH:D016190,Chemical) :: ['carboplatin']
